House Dust Mite Allergy
📧 Sign up to get email alerts when something new happens for House Dust Mite Allergy.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-02-05Clinical Trial Update: Prospective Study About Sensitization Pattern to Insects as Food Source in Patients With House Dust Mite Allergy [NA]
This completed prospective study investigated sensitization patterns to insects as a food source in patients with house dust mite allergy.
-
CLINICAL_TRIALS research · 2025-10-27Clinical Trial Update: A Study to Assess the Safety, Tolerability and Immunological Response of ASP2390 in Adult Subjects Allergic to House Dust Mites [Phase 1]
This is a Phase 1 study evaluating the safety, tolerability and immunological response of ASP2390 in adults with house dust mite allergy. Th…
-
CLINICAL_TRIALS research · 2025-06-10Clinical Trial Update: Potency of HDM Sublingual AIT Tablets in Assuring the Persistency of Asthma Control in HDM Allergic Patients With Severe Asthma, Treated With Tezepelumab [Phase 3]
A Phase 3 trial update evaluating whether house dust mite SLIT tablets can sustain asthma control in patients with severe asthma who are tre…
-
CLINICAL_TRIALS trial_result · 2025-01-31Clinical Trial Update: Evaluation of an Adjusted Cutoff Value for S.P.A.T (Skin Prick Automated Test) Device in Allergic Subjects [NA]
This clinical trial update reports the completion of evaluating an adjusted cutoff value for the Skin Prick Automated Test (SPAT) device in …
-
CLINICAL_TRIALS trial_result · 2024-10-15Clinical Trial Update: Skin Responses and T Cell Immunology After House Dust Mite Exposure in Sensitized Atopic Dermatitis Patients [NA]
This clinical trial update reports skin responses and T cell immunology following house dust mite exposure in individuals with sensitized at…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2024-08-09Clinical Trial Update: Interest of Nasal Provocation Tests for Diagnosis of House Mites Allergic Rhinitis [Phase 4]
Phase 4 trial evaluating nasal provocation tests for diagnosis of house dust mite allergic rhinitis was terminated.
-
CLINICAL_TRIALS research · 2024-07-18Clinical Trial Update: Efficacy and Safety Assessment of Beltavac® With Polymerized Extract of HDM [Phase 3]
A Phase 3 clinical trial evaluating Beltavac with a polymerized extract of house dust mite for house dust mite allergy is ongoing, focusing …
-
CLINICAL_TRIALS trial_result · 2023-10-23Clinical Trial Update: Clinical Trial to Evaluate the Efficacy and Safety of Polymerized, Mannan-Conjugated Dermatophagoides Allergen Extract [Phase 2, Phase 3]
Clinical trial update for a Phase 2/3 study evaluating a polymerized, mannan-conjugated Dermatophagoides allergen extract for allergic rhini…
-
CLINICAL_TRIALS trial_result · 2022-11-18Clinical Trial Update: Efficacy and Safety Evaluation for the Treatment of HDM Induced Allergic Asthma and Rhinitis/Rhinoconjunctivitis [Phase 3]
Phase 3 clinical trial evaluating efficacy and safety for treatment of house dust mite–induced allergic asthma and perennial allergic rhinit…
-
CLINICAL_TRIALS trial_result · 2022-02-08Clinical Trial Update: Effects of Tregalizumab on Allergen-induced Airway Responses and Airway Inflammation in Asthmatic Patients [Phase 2]
Phase 2 trial assessing the effects of tregalizumab on allergen-induced airway responses and airway inflammation in patients with allergic a…
-
CLINICAL_TRIALS trial_result · 2019-09-25Clinical Trial Update: Efficacy & Safety of STG320 Sublingual Tablets of HDM Allergen Extracts in Adults and Adolescents With HDM-associated AR [Phase 3]
Phase 3 trial assessing the efficacy and safety of STG320 sublingual tablets containing house dust mite allergen extracts in adults and adol…
-
CLINICAL_TRIALS trial_result · 2017-03-29Clinical Trial Update: Safety and Clinical Tolerability of hdmASIT+TM Peptides Administered in HDM-induced Allergic Patients [Phase 2]
Phase 2 trial evaluating the safety and clinical tolerability of hdmASIT+TM peptides in house dust mite allergy patients has completed. The …
-
CLINICAL_TRIALS trial_result · 2017-01-30Clinical Trial Update: A One Year Trial Evaluating the Safety and Efficacy of the ALK House Dust Mite Allergy Tablet [Phase 3]
A Phase 3 trial evaluating the safety and efficacy of the ALK House Dust Mite Allergy Tablet has completed.
-
CLINICAL_TRIALS trial_result · 2015-12-18Clinical Trial Update: Dose Ranging Study of SLIT Tablets of House Dust Mite Allergen Extracts (HDM) in Adults With HDM-associated Allergic Asthma [Phase 2]
This is an update on a Phase 2 dose-ranging study evaluating sublingual immunotherapy tablets containing house dust mite allergen extracts i…
-
CLINICAL_TRIALS research · 2015-12-03Clinical Trial Update: AZELASTINE/FLUTICASONE (AZE/FLU) Nasal Spray on Symptom Control, Nasal Mediators and Nasal Hyperresponsiveness in Allergic Rhinitis (AR) [Phase 4]
A Phase 4 clinical trial update evaluating azelastine/fluticasone nasal spray for symptom control, nasal mediators, and nasal hyperresponsiv…
-
CLINICAL_TRIALS trial_result · 2015-12-02Clinical Trial Update: SUBLIVAC FIX Mite Mixture Dose Tolerability Study [Phase 1, Phase 2]
Phase 1/2 dose-tolerability study of SUBLIVAC FIX Mite Mixture for house dust mite allergy has completed.
-
CLINICAL_TRIALS withdrawal · 2015-03-27Clinical Trial Update: Role of Indoor Pollutants on House Dust Mite Allergic Asthma [NA]
This clinical trial update indicates that the NCT01019291 study on indoor pollutants and house dust mite–related allergic asthma has been wi…
-
CLINICAL_TRIALS trial_result · 2014-07-01Clinical Trial Update: Safety Study of Sublingual Immunotherapy Tablets of House Dust Mite Allergen Extracts [Phase 1]
Phase 1 safety study update of sublingual immunotherapy tablets containing house dust mite allergen extracts; the trial status is completed.
-
CLINICAL_TRIALS trial_result · 2014-05-15Clinical Trial Update: ToleroMune House Dust Mite Follow on Study
ToleroMune was studied in a follow-on trial for house dust mite allergy and rhinoconjunctivitis; the study status is listed as completed.
-
CLINICAL_TRIALS trial_result · 2013-07-11Clinical Trial Update: A Study to Investigate an Immunomodulatory Therapy in Adult Patients With Perennial Allergic Rhinoconjunctivitis [Phase 2]
Phase 2 trial evaluating an immunomodulatory therapy in adults with perennial allergic rhinitis and house dust mite allergy; results were po…
-
CLINICAL_TRIALS trial_result · 2011-11-24Clinical Trial Update: Induction of Allergen Specific Bronchial Immunotolerance After Specific Immunotherapy
This completed clinical trial evaluated whether induction of allergen-specific bronchial immunotolerance can be achieved after specific immu…
-
CLINICAL_TRIALS trial_result · 2011-10-12Clinical Trial Update: A Phase III Study to Assess Efficacy and Safety of STALORAL® 300 IR Sublingual Immunotherapy (SLIT) in Asthmatic Patients Allergic to House-dust Mites [Phase 3]
Phase III trial evaluating the efficacy and safety of STALORAL 300 IR Sublingual Immunotherapy in asthmatic patients allergic to house-dust …
-
CLINICAL_TRIALS trial_result · 2010-12-29Clinical Trial Update: The Effect of Autologous Autovaccine in Patients With Allergy on House-dust-mite [Phase 1]
Phase 1 trial assessing an autologous autovaccine for house dust mite allergy has completed.
-
CLINICAL_TRIALS trial_result · 2010-11-10Clinical Trial Update: Safety of ToleroMune House Dust Mite (HDM) to Treat House Dust Mite Allergy in HDM Allergic Subjects With Rhinoconjunctivitis [Phase 2]
This clinical trial update notes the completion of a Phase 2 study evaluating the safety of ToleroMune for house dust mite allergy in subjec…
-
CLINICAL_TRIALS trial_result · 2009-04-27Clinical Trial Update: A Study to Investigate an Immunomodulatory Therapy in Adult Patients With Perennial Allergic Rhinoconjunctivitis [Phase 2]
A Phase 2 trial investigating an immunomodulatory therapy for adults with perennial allergic rhinoconjunctivitis (including house dust mite …